Next Generation MarginProbeTM

Dilon Technologies Announces Beginning Enrollment in its Pivotal Trial of the Next Generation MarginProbeTM 2 Used in Real-Time Margin Assessment. NEWPORT NEWS, VA, Feb 5, 2024 (PRNewswire) –Dilon Technologies Inc. announced today the enrollment of its first patient in the Prospective, Single-Arm, Multi-Center Pivotal Trial for its next generation MarginProbe 2 product used in real-time…

Read More

Publication of Data Demonstrating

Ductal Carcinoma in Situ Diagnosis

Dilon Technologies Announces the Publication of Data Demonstrating Cost-Savings Results from the Use of MarginProbeTM Compared to a Full Cavity Shave (FCS) Approach NEWPORT NEWS, VA, Sep 22, 2023 (PRNewswire) –Dilon Technologies Inc. announced today the publication of Cost Minimization in Breast Conserving Surgery: A Comparative Study of Radiofrequency Spectroscopy and Full Cavity Shave Margins…

Read More